ID RHD XT

"ID RHD XT is a qualitative, PCR-based and hybridization-based genotyping test for the simultaneous identification of six alleles of the RHD gene and two alleles of the ITGB3 gene in genomic DNA extracted from whole blood specimens collected in EDTA. This test can be used to type the following allelic variants of the RHD gene: RHD*weak D type 1, RHD*weak D type 2, RHD*weak D type 3, RHD deletion, RHD*Pseudogene and RHD*DIIIa-CE(3-7)-D and ITGB3 gene (HPA-1 system): HPA1a and HPA1b. ID RHD XT can be used to genotype and predict Rh and HPA-1 phenotypes in patients and/or blood donors. The product is intended for professional use in a laboratory environment. The genotypes and predicted phenotype results will be reported from the combination of the allelic variants tested. The RHD predicted phenotype result should be always interpreted within the clinical context and serology data.
ID RHD XT ANALYSIS SOFTWARE is a qualitative software application designed to transform Luminex system (Luminex 200 or FLEXMAP 3D) readings (CSV output) from Progenika Biopharma´s ID RHD XT assay into a genotype and predicted phenotype for each of the blood group systems analyzed in the assay. The product is intended for professional use in a laboratory environment"